Bristol Myers Squibb Increases Quarterly Dividend for 17th Consecutive Year
New York, Thursday, 11 December 2025.
Bristol Myers Squibb announced a 1.6% increase in its quarterly dividend, marking the 17th consecutive year of increases and reinforcing its commitment to shareholder value.
Details of the Dividend Increase
Bristol Myers Squibb (NYSE: BMY) declared an increase in its quarterly dividend to $0.63 per share, a 1.6% rise from the previous rate of $0.62 per share. This adjustment demonstrates the company’s sustained commitment to enhancing shareholder value. The dividend is scheduled to be paid on February 2, 2026, to stockholders recorded as of January 2, 2026 [1].
Historical Context and Future Outlook
This announcement marks the 17th consecutive year that Bristol Myers Squibb has elevated its dividend payouts, underscoring its financial resilience and strategic focus on rewarding investors. The company has maintained a consistent dividend payment record for 94 years, reflecting its stability and growth in the pharmaceutical sector [1][2].
Projected Annual Dividend Rate
With the new quarterly dividend in place, the projected annual dividend for the fiscal year 2026 is set at $2.52 per share. This forecasted figure aligns with the company’s strategy to consistently return capital to shareholders, even amidst a competitive market landscape [1][3].
Broader Implications for Investors
The dividend increase signals Bristol Myers Squibb’s robust financial health and confidence in its ongoing operations. This move is likely to appeal to income-focused investors who prioritize stable and growing dividends. As the company continues to innovate within the pharmaceutical industry, its financial strategies aim to reassure and attract long-term investors [3].